IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe • Euronext Lisbon • ELI:IBS • PTIBS0AM0008
10.75 EUR
+0.1 (+0.94%)
Last: Feb 2, 2026, 02:24 PM
We assign a fundamental rating of 4 out of 10 to IBS. IBS was compared to 59 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of IBS get a neutral evaluation. Nothing too spectacular is happening here. IBS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year IBS was profitable.
- In the past year IBS had a positive cash flow from operations.
- Of the past 5 years IBS 4 years were profitable.
- In the past 5 years IBS always reported a positive cash flow from operatings.
1.2 Ratios
- IBS's Return On Assets of 1.91% is on the low side compared to the rest of the industry. IBS is outperformed by 62.71% of its industry peers.
- IBS's Return On Equity of 4.21% is in line compared to the rest of the industry. IBS outperforms 55.93% of its industry peers.
- The Return On Invested Capital of IBS (4.53%) is comparable to the rest of the industry.
- IBS had an Average Return On Invested Capital over the past 3 years of 3.32%. This is significantly below the industry average of 13.35%.
- The last Return On Invested Capital (4.53%) for IBS is above the 3 year average (3.32%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.91% | ||
| ROE | 4.21% | ||
| ROIC | 4.53% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
- With a Profit Margin value of 2.56%, IBS is not doing good in the industry: 61.02% of the companies in the same industry are doing better.
- In the last couple of years the Profit Margin of IBS has declined.
- With a Operating Margin value of 5.83%, IBS perfoms like the industry average, outperforming 40.68% of the companies in the same industry.
- IBS's Operating Margin has declined in the last couple of years.
- IBS's Gross Margin of 52.62% is in line compared to the rest of the industry. IBS outperforms 59.32% of its industry peers.
- IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.83% | ||
| PM (TTM) | 2.56% | ||
| GM | 52.62% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
- Compared to 1 year ago, IBS has less shares outstanding
- The number of shares outstanding for IBS has been increased compared to 5 years ago.
- The debt/assets ratio for IBS is higher compared to a year ago.
2.2 Solvency
- IBS has an Altman-Z score of 2.14. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
- IBS has a Altman-Z score of 2.14. This is comparable to the rest of the industry: IBS outperforms 57.63% of its industry peers.
- The Debt to FCF ratio of IBS is 3.47, which is a good value as it means it would take IBS, 3.47 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.47, IBS is in the better half of the industry, outperforming 71.19% of the companies in the same industry.
- IBS has a Debt/Equity ratio of 0.66. This is a neutral value indicating IBS is somewhat dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.66, IBS is doing good in the industry, outperforming 72.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 3.47 | ||
| Altman-Z | 2.14 |
ROIC/WACC0.72
WACC6.26%
2.3 Liquidity
- A Current Ratio of 1.02 indicates that IBS should not have too much problems paying its short term obligations.
- The Current ratio of IBS (1.02) is better than 62.71% of its industry peers.
- A Quick Ratio of 0.92 indicates that IBS may have some problems paying its short term obligations.
- IBS has a Quick ratio (0.92) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
- The earnings per share for IBS have decreased strongly by -16.66% in the last year.
- Measured over the past years, IBS shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
- The Revenue has grown by 15.02% in the past year. This is quite good.
- IBS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.46% yearly.
EPS 1Y (TTM)-16.66%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%83.33%
Revenue 1Y (TTM)15.02%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%7.53%
3.2 Future
- The Earnings Per Share is expected to grow by 17.57% on average over the next years. This is quite good.
- IBS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.42% yearly.
EPS Next Y-38.06%
EPS Next 2Y-0.66%
EPS Next 3Y2.31%
EPS Next 5Y17.57%
Revenue Next Year15.95%
Revenue Next 2Y10.49%
Revenue Next 3Y8.64%
Revenue Next 5Y7.42%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 31.62, IBS can be considered very expensive at the moment.
- IBS's Price/Earnings ratio is in line with the industry average.
- IBS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.32.
- IBS is valuated quite expensively with a Price/Forward Earnings ratio of 33.97.
- 61.02% of the companies in the same industry are cheaper than IBS, based on the Price/Forward Earnings ratio.
- IBS's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.62 | ||
| Fwd PE | 33.97 |
4.2 Price Multiples
- IBS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IBS is cheaper than 84.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.39 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.66%
EPS Next 3Y2.31%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 6.60%, IBS is a good candidate for dividend investing.
- IBS's Dividend Yield is rather good when compared to the industry average which is at 1.34. IBS pays more dividend than 100.00% of the companies in the same industry.
- IBS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.6% |
5.2 History
- On average, the dividend of IBS grows each year by 48.65%, which is quite nice.
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- IBS pays out 213.50% of its income as dividend. This is not a sustainable payout ratio.
- IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP213.5%
EPS Next 2Y-0.66%
EPS Next 3Y2.31%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
Can you provide the valuation status for IBERSOL SGPS SA?
ChartMill assigns a valuation rating of 2 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
What is the financial health of IBERSOL SGPS SA (IBS.LS) stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
Can you provide the dividend sustainability for IBS stock?
The dividend rating of IBERSOL SGPS SA (IBS.LS) is 6 / 10 and the dividend payout ratio is 213.5%.